Mental Disorders

Use of Mixed Amphetamine Salts in a Patient with Depersonalization/Derealization Disorder
by Samuel R. Weber, MD Dr. Weber is with Intermountain Healthcare in Logan, Utah. FUNDING: No funding was provided for this study. DISCLOSURES: The author has no conflicts of interest relevant to the content of this article. ABSTRACT: Depersonalization and derealization symptoms are common and often transient. Recurrent, persistent symptoms can result in a diagnosis […]

Dismantling Fears Associated with Intellectual Disability Psychotherapy: An Evidence-based Practice
by Jessica A. Porcelan, MD; Katherine E. Caujolle-Alls, MD; and Julie P. Gentile, MD Drs. Porcelan, Caujolle-Alls, and Gentile are with the Department of Psychiatry at Wright State University in Dayton, Ohio. Funding: No funding was provided. Disclosures: The authors have no conflicts of interest relevant to the content of this article. Department editor Allison […]

Effectiveness of Electroconvulsive Therapy (ECT) in Parkinsonian Symptoms: A Case Series
by Sandeep Grover, MD; Aditya Somani, MD; Neeru Sahni, MD; Sahil Mehta, DM; Swati Choudhary, MBBS; Rahul Kumar Chakravarty, MBBS; and Anju Moni Rabha, MBBS Drs. Grover, Somani, Sahni, Mehta, Choudhary, Chakravarty, and Rabha are with the Post Graduate Institute of Medical Education and Research, Chadigarh in Chandigarh, India. Innov Clin Neurosci. 2017;15(1–2):23–27. FUNDING: No […]

The 30th Anniversary of PANSS Special Edition
Dear Colleagues: Thirty years ago, the Positive and Negative Syndrome Scale (PANSS) was developed and published by Stanley Kay, Abraham Fiszbein, and Lewis Opler to identify the presence and severity of psychopathology symptoms in patients with psychotic disorders, with the objective of measuring patient characteristics and evaluating change over time using 30 symptoms rated on […]

Using the Positive and Negative Syndrome Scale (PANSS) to Define Different Domains of Negative Symptoms: Prediction of Everyday Functioning by Impairments in Emotional Expression and Emotional Experience
by Philip D. Harvey, PhD; Anzalee Khan, PhD; and Richard S. E. Keefe, PhD Dr. Harvey is Professor of Psychiatry and Behavioral Sciences at University of Miami School of Medicine in Miami, Florida. Dr. Khan is Senior Biostatistician at NeuroCog Trials and holds an appointment in the Psychopharmacology Research Program at the Nathan S. Kline […]

Insight and Treatment Outcomes in Schizophrenia: Post-hoc Analysis of a Long-term, Double-blind Study Comparing Lurasidone and Quetiapine XR
by Philip D. Harvey, PhD; Cynthia O. Siu, PhD; and Antony D. Loebel, MD Dr. Harvey is with the University of Miami Miller School of Medicine in Miami, Florida, and the Research Service of the Bruce W. Carter VA Medical Center in Miami, Florida. Dr. Siu is with COS and Associates Ltd. in Central District, […]

Negative Symptom Dimensions of the Positive and Negative Syndrome Scale Across Geographical Regions: Implications for Social, Linguistic, and Cultural Consistency
by Anzalee Khan, PhD; Lora Liharska, MS; Philip D. Harvey, PhD; Alexandra Atkins, PhD; Daniel Ulshen, BA; and Richard S.E. Keefe, PhD Dr. Khan is Senior Biostatistician at NeuroCog Trials and holds an appointment in the Psychopharmacology Research Program at the Nathan S. Kline Institute for Psychiatric Research in Orangeburg, New York. Ms. Liharska is […]
How the COVID-19 Pandemic is Changing Mental Health Disease Management: The Growing Need of Telecounseling in Italy
by Rosaria De Luca, MSc, PhD, and Rocco Salvatore Calabrò, MD, PhD Drs. De Luca and Calabrò are with the IRCCS Centro Neurolesi Bonino-Pulejo in Messina, Italy. FUNDING: No funding was provided for this study. DISCLOSURES: The author has no conflicts of interest relevant to the content of this article. ABSTRACT: Coronavirus-19 (COVID-19) is a […]
Continue Reading